[Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas]. (Record no. 21391888)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01456 a2200409 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516070753.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201204s 0 0 chi d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0529-5807 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Shen, Xu-xia |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20120405 |
245 00 - TITLE STATEMENT | |
Title | [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas]. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Zhonghua bing li xue za zhi = Chinese journal of pathology |
Date of publication, distribution, etc. | Aug 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 511-6 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: English Abstract; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | CA-125 Antigen |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cystadenocarcinoma, Serous |
General subdivision | classification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Follow-Up Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunohistochemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ki-67 Antigen |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Membrane Proteins |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Grading |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ovarian Neoplasms |
General subdivision | classification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ovary |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | PAX2 Transcription Factor |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Suppressor Protein p53 |
General subdivision | metabolism |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yu, Lin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bi, Rui |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yang, Wen-tao |
773 0# - HOST ITEM ENTRY | |
Title | Zhonghua bing li xue za zhi = Chinese journal of pathology |
Related parts | vol. 40 |
-- | no. 8 |
-- | p. 511-6 |
No items available.